Three Renowned Indian Institutes Developed A More Effective Cancer Treatment
Aadhya Khatri - Jan 16, 2020
A new combination of cancer treatment has recently been perfected by the collective effort of experts from three renowned institutes in India
- Samsung To Build A 500 Million-Worth Display Manufacturing Facility In India
- Drone Owners To Register Their Vehicles Before Jan 31 Or Face Strict Penalties
- First Mission OF 2020: ISRO To Launch GSAT-3 To Improve Internet And TV Signals
A new combination of cancer treatment has recently been perfected by the collective effort of experts from Bose Institute in Kolkata, IIT Bombay, and the Indian Institute of Technology Hyderabad.
This method consists of chemotherapy and photothermal therapy, which results in a desirable outcome. The combination decreased the chance of the patients developing resistant cancer cells.
The method is still in its infant stage of development but if it can prove useful on humans, the therapy will be new hope for cancer patients who are too weak to put up with chemotherapy. It can also lower the cost of treating cancer in India.
If you are unfamiliar with some of the terms, here is an explanation. Photothermal therapy involves applying heat to a specific area to kill cancer cells while chemotherapy is the treatment that uses chemicals to achieve a similar result.
The experts tested the method on mice carrying breast cancer cells and the result is the tumor cells decreased in number while the adverse effects are minimized.
What the scientists hope to achieve with this method is that it can kill cancer cells without weakening the overall immunity of the body. It might even be effective on patients who are too weak to receive chemicals or those who have been too far along with cancer.
What comes next for the method in clinical trials and bureaucratic approvals, which will definitely take a lot of time before we can see this cancer treatment being used on a patient.
Technology is developing fast and we have reason to believe that we will soon have more in our armory to deal with cancer.
The fact that the method is created in India means that it might be more affordable to around 2.25 million Indian patients.